
Puma Biotechnology Investor Relations Material
Latest events

Q1 2025
Puma Biotechnology
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Puma Biotechnology Inc
Access all reports
Puma Biotechnology Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of cancer. The company specializes in targeted oncology, developing drugs that aim to improve outcomes for patients with specific types of cancer by addressing unmet medical needs. It collaborates with healthcare professionals, researchers, and regulatory bodies to advance its clinical and commercial objectives. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.
Key slides for Puma Biotechnology Inc


Q2 2024
Puma Biotechnology Inc


Q4 2024
Puma Biotechnology Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PBYI
Country
🇺🇸 United States